Diagnosis of Immunodeficiency Diseases

2000 ◽

Vol 12 (6) ◽

pp. 0267-0270 ◽

Cited By ~ 1

Author(s):

Brian Eley ◽

David Beatty

Keyword(s):

Primary Immunodeficiency ◽

Cape Town ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text

The level of knowledge about primary immunodeficiency diseases among medical students in Riyadh city, Saudi Arabia

International Journal of Medicine in Developing Countries ◽

10.24911/ijmdc.51-1607186256 ◽

2021 ◽

pp. 261-266

Author(s):

Nawaf Alghamdi ◽

Abdulrahman Alajlan ◽

Nawaf Almuzaini ◽

Fatmah Othman ◽

Fayhan Roqi ◽

...

Keyword(s):

Saudi Arabia ◽

Medical Students ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Riyadh City ◽

Level Of Knowledge

Download Full-text

PRIMARY IMMUNODEFICIENCY DISEASES (PID) ASSOCIATED NEOPLASIA IN A TERTIARY CENTRE

10.26226/morressier.57bc1758d462b80290b4d300 ◽

2016 ◽

Author(s):

Laura Marques

Keyword(s):

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Tertiary Centre

Download Full-text

GENETIC ANALYSIS AND MOLECULAR DIAGNOSIS OF IRANIAN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES

10.26226/morressier.57bc1758d462b80290b4d32d ◽

2016 ◽

Author(s):

Hassan Abolhassani

Keyword(s):

Genetic Analysis ◽

Primary Immunodeficiency ◽

Molecular Diagnosis ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Iranian Patients

Download Full-text

THE PRIMARY IMMUNODEFICIENCY RESEARCH GROUP: A MULTIDISCPLINARY TEAM PROVIDING MOLECULAR DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES IN SOUTH AFRICA

10.26226/morressier.57bc1758d462b80290b4d2dd ◽

2016 ◽

Author(s):

Craig Kinnear

Keyword(s):

South Africa ◽

Primary Immunodeficiency ◽

Molecular Diagnosis ◽

Research Group ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Group A

Download Full-text

ANALYSES OF EFFICACY AND TOLERABILITY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PID) TREATED BY DIFFERENT MODES OF ADMINISTRATION OF IMMUNOGLOBULIN THERAPY DURING THREE CONSECUTIVE STUDIES

10.26226/morressier.594a7d48d462b8028d8938d3 ◽

2017 ◽

Author(s):

Kim Haines

Keyword(s):

Primary Immunodeficiency ◽

Immunoglobulin Therapy ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text

INTERIM RESULTS OF A POST-AUTHORIZATION SAFETY STUDY (PASS) ON THE LONG-TERM SAFETY OF FACILITATED SCIG 10% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES IN THE US

10.26226/morressier.594a7d48d462b8028d8938ce ◽

2017 ◽

Author(s):

Kim Haines

Keyword(s):

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Safety Study ◽

Immunodeficiency Diseases ◽

The Us

Download Full-text

ADVERSE EVENTS (AES) AND TOLERABILITY OF THE NEW HUMAN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG 20%) IN PEDIATRIC PATIENTS (<18 YEARS OLD) WITH PRIMARY IMMUNODEFICIENCY DISEASES (PID)

10.26226/morressier.594a7d48d462b8028d8938c9 ◽

2017 ◽

Author(s):

Kim Haines

Keyword(s):

Adverse Events ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Subcutaneous Immunoglobulin ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text

Registry and biobank establishment of inflammatory bowel disease suspected to primary immunodeficiency diseases for the first time in Iran and as a partner of international campaign

10.26226/morressier.5acc8ad1d462b8028d89af6b ◽

2018 ◽

Author(s):

Roya Sherkat

Keyword(s):

Inflammatory Bowel Disease ◽

Primary Immunodeficiency ◽

Bowel Disease ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Inflammatory Bowel ◽

First Time

Download Full-text

Study to Monitor the Safety, Tolerability and Efficacy of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases, Including (But Not Limited to) Those Who Have Completed the SCGAM-01 Trial

Case Medical Research ◽

10.31525/ct1-nct03907241 ◽

2019 ◽

Author(s):

Keyword(s):

Primary Immunodeficiency ◽

Human Immunoglobulin ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text

Diagnosis of Immunodeficiency Diseases

Primary Immunodeficiency Diseases in Cape Town

The level of knowledge about primary immunodeficiency diseases among medical students in Riyadh city, Saudi Arabia

PRIMARY IMMUNODEFICIENCY DISEASES (PID) ASSOCIATED NEOPLASIA IN A TERTIARY CENTRE

GENETIC ANALYSIS AND MOLECULAR DIAGNOSIS OF IRANIAN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES

THE PRIMARY IMMUNODEFICIENCY RESEARCH GROUP: A MULTIDISCPLINARY TEAM PROVIDING MOLECULAR DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES IN SOUTH AFRICA

ANALYSES OF EFFICACY AND TOLERABILITY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PID) TREATED BY DIFFERENT MODES OF ADMINISTRATION OF IMMUNOGLOBULIN THERAPY DURING THREE CONSECUTIVE STUDIES

INTERIM RESULTS OF A POST-AUTHORIZATION SAFETY STUDY (PASS) ON THE LONG-TERM SAFETY OF FACILITATED SCIG 10% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES IN THE US

ADVERSE EVENTS (AES) AND TOLERABILITY OF THE NEW HUMAN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG 20%) IN PEDIATRIC PATIENTS (<18 YEARS OLD) WITH PRIMARY IMMUNODEFICIENCY DISEASES (PID)

Registry and biobank establishment of inflammatory bowel disease suspected to primary immunodeficiency diseases for the first time in Iran and as a partner of international campaign

Study to Monitor the Safety, Tolerability and Efficacy of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases, Including (But Not Limited to) Those Who Have Completed the SCGAM-01 Trial

Export Citation Format